Connor, Clark & Lunn Investment Management Ltd. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,146,740
-34.4%
265,4490.0%0.01%
-33.3%
Q2 2023$1,749,309
+14.9%
265,449
+18.4%
0.01%
+12.5%
Q1 2023$1,521,979
-5.9%
224,150
+2.4%
0.01%
-11.1%
Q4 2022$1,616,991
+37.6%
218,808
+84.0%
0.01%
+12.5%
Q3 2022$1,175,000
+55.0%
118,930
+71.0%
0.01%
+60.0%
Q2 2022$758,000
+56.6%
69,548
+64.3%
0.01%
+66.7%
Q2 2020$484,000
+128.3%
42,341
+67.4%
0.00%
+50.0%
Q1 2016$212,000
-72.9%
25,300
-69.9%
0.00%
-71.4%
Q4 2015$782,000
-22.9%
84,000
-6.6%
0.01%
-12.5%
Q3 2015$1,014,000
+476.1%
89,900
+375.7%
0.01%
+700.0%
Q1 2015$176,000
-65.8%
18,900
-47.4%
0.00%
-75.0%
Q4 2014$514,000
-80.2%
35,900
-75.2%
0.00%
-78.9%
Q1 2014$2,595,000144,7070.02%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders